Phase I Study Supports Therapeutic Potential of Polatuzumab Vedotin in non-Hodgkin Lymphoma. PSMA ADC Produces Clinically Relevant Declines in PSA and CTC Counts. Enhancing ADCs to Target Diseased Cells and Deliver Payloads. Seattle Genetics and Bristol-Myers Squibb Evaluate New Combination of Brentuximab Vedotin and Nivolumab. and Bristol-Myers Squibb Company have entered into a clinical trial collaboration to evaluate the investigational c.

Discover more about the Babraham Research Campus, including our facilities, campus community life and job vacancies. We have a number of versatile conferencing and meeting spaces on campus. Find out more about them all here. Supporting and promoting the regional and UK bioscience ecosystem. World class research and business come together to promote innovation .

The World Bispecific Summit will unite the leading bispecific drug developers to enable you to realize the clinical potential of your bispecific therapeutics. Uniquely positioned as the only meeting specifically focused on bispecifics, the 3 packed days of in-depth insights and case studies that will be shared will enable you to accelerate the progression of your bispecific candidates into and through the clinic more rapidly and robustly.

RAISED FOR OUR CLIENTS SINCE 2013. We are a leading investment bank and stockbroker dedicated to serving the small and mid cap sector in the UK. N 1 Singer shares its Q1 2018 Review. In our Q1 2018 review, we discuss the UK economic and equity market environment and notable transactions completed in the first quarter of 2018. FreeAgent acquired by RBS for 53 million.

Our 400-plus Member companies are located across the Golden Triangle and beyond to Manchester, Nottingham, the Midlands, South Coast and Scotland, benefiting from our. OBN ist ein gemeinnütziger Verband in Großbritannien, der eine führende Stellung bei der Unterstützung und Vernetzung.